Skip to main content
Erschienen in: Neurological Sciences 12/2019

20.07.2019 | Original Article

Genetic and lifestyle predictors of ischemic stroke severity and outcome

verfasst von: Ivana Celap, Nora Nikolac Gabaj, Vida Demarin, Vanja Basic Kes, Ana-Maria Simundic

Erschienen in: Neurological Sciences | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Different models that include clinical variables and blood markers have been investigated to predict acute ischemic stroke treatment course and recovery.

Aim

The aim of the study was to investigate associations between lipid levels, lifestyle factors, hemostatic (F5, F2, SERPINE1, F13A1, and FGB), and atherogenic (APOA5 and ACE) gene variants and acute ischemic stroke (AIS) severity.

Materials and methods

This study included 250 patients with AIS in which F5, F2, SERPINE1, F13A1, FGB, APOA5, and ACE genotypes were determined. Total cholesterol (TC), high-density cholesterol, low-density cholesterol, and triglycerides concentrations were measured within 24 h of the AIS onset. Examination of the neurological deficit was done using National Institutes of Health Stroke Scale/Score (NIHSS).

Results

APOA5 genotype [TC + CC] was more frequent (P = 0.026) in patients with the NIHSS score ≥ 21. Univariate regression analysis has shown that triglycerides (OR 0.55, 95% CI 0.34–0.91; P = 0.019), obesity (0.28, 95% CI 0.10–0.73; P = 0.010), age (OR 1.08, 95% CI 1.04–1.13; P < 0.001), and APOA5 genotype (TC + CC) (OR 2.40, 95% CI 1.10–5.25; P = 0.034) are significantly associated with a severe stroke. When all variables were included in model age (OR 1.06, 95% CI 1.01–1.11; P = 0.018), obesity (OR 0.25, 95% CI 0.08–0.77; P = 0.016) and APOA5 genotype (TC + CC) (OR 3.26, 95% CI 1.29–8.23; P = 0.012) remained significant for the risk of severe AIS.

Conclusion

APOA5 genotype (TC + CC), age, and obesity could be used as prognostic risk factors for a very severe stroke (NIHSS ≥ 21).
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Harvey RL (2015) Predictors of functional outcome following stroke. Phys Med Rehabil Clin N Am 26:583–598PubMedCrossRef Harvey RL (2015) Predictors of functional outcome following stroke. Phys Med Rehabil Clin N Am 26:583–598PubMedCrossRef
2.
Zurück zum Zitat Veerbeek JM, Kwakkel G, Van Wegen EEH, Ket JCF, Heymans MW (2011) Early prediction of outcome of activities of daily living after stroke: a systematic review. Stroke 42:1482–1488PubMedCrossRef Veerbeek JM, Kwakkel G, Van Wegen EEH, Ket JCF, Heymans MW (2011) Early prediction of outcome of activities of daily living after stroke: a systematic review. Stroke 42:1482–1488PubMedCrossRef
3.
Zurück zum Zitat Woldag H, Gerhold LL, de Groot M, Wohlfart K, Wagner A, Hummelsheim H (2006) Early prediction of functional outcome after stroke. Brain Inj 20:1047–1052PubMedCrossRef Woldag H, Gerhold LL, de Groot M, Wohlfart K, Wagner A, Hummelsheim H (2006) Early prediction of functional outcome after stroke. Brain Inj 20:1047–1052PubMedCrossRef
4.
Zurück zum Zitat Bentsen L, Christensen L, Christensen A, Christensen H (2014) Outcome and risk factors presented in old patients above 80 years of age versus younger patients after ischemic stroke. J Stroke Cerebrovasc Dis 23:1944–1948PubMedCrossRef Bentsen L, Christensen L, Christensen A, Christensen H (2014) Outcome and risk factors presented in old patients above 80 years of age versus younger patients after ischemic stroke. J Stroke Cerebrovasc Dis 23:1944–1948PubMedCrossRef
5.
Zurück zum Zitat Rojas JI, Zurrú MC, Romano M, Patrucco L, Cristiano E (2007) Acute ischemic stroke and transient ischemic attack in the very old-risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years. Eur J Neurol 14:895–899PubMedCrossRef Rojas JI, Zurrú MC, Romano M, Patrucco L, Cristiano E (2007) Acute ischemic stroke and transient ischemic attack in the very old-risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years. Eur J Neurol 14:895–899PubMedCrossRef
6.
Zurück zum Zitat Sato S, Toyoda K, Uehara T, Toratani N, Yokota C, Moriwaki H, Naritomi H, Minematsu K (2008) Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes. Neurology. 70:2371–2377PubMedCrossRef Sato S, Toyoda K, Uehara T, Toratani N, Yokota C, Moriwaki H, Naritomi H, Minematsu K (2008) Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes. Neurology. 70:2371–2377PubMedCrossRef
7.
Zurück zum Zitat Osei E, Fonville S, Zandbergen AAM, Koudstaal PJ, Dippel DWJ, den Hertog HM (2017) Glucose in prediabetic and diabetic range and outcome after stroke. Acta Neurol Scand 135:170–175PubMedCrossRef Osei E, Fonville S, Zandbergen AAM, Koudstaal PJ, Dippel DWJ, den Hertog HM (2017) Glucose in prediabetic and diabetic range and outcome after stroke. Acta Neurol Scand 135:170–175PubMedCrossRef
8.
Zurück zum Zitat Tanaka R, Ueno Y, Miyamoto N, Yamashiro K, Tanaka Y, Shimura H, Hattori N, Urabe T (2013) Impact of diabetes and prediabetes on the short-term prognosis in patients with acute ischemic stroke. J Neurol Sci 332:45–50PubMedCrossRef Tanaka R, Ueno Y, Miyamoto N, Yamashiro K, Tanaka Y, Shimura H, Hattori N, Urabe T (2013) Impact of diabetes and prediabetes on the short-term prognosis in patients with acute ischemic stroke. J Neurol Sci 332:45–50PubMedCrossRef
9.
Zurück zum Zitat Tziomalos K, Giampatzis V, Bouziana SD, Spanou M, Kostaki S, Papadopoulou M, Angelopoulou SM, Tsopozidi M, Savopoulos C, Hatzitolios AI (2017) Prognostic significance of major lipids in patients with acute ischemic stroke. Metab Brain Dis 32:395–400PubMedCrossRef Tziomalos K, Giampatzis V, Bouziana SD, Spanou M, Kostaki S, Papadopoulou M, Angelopoulou SM, Tsopozidi M, Savopoulos C, Hatzitolios AI (2017) Prognostic significance of major lipids in patients with acute ischemic stroke. Metab Brain Dis 32:395–400PubMedCrossRef
10.
Zurück zum Zitat Jain M, Jain A, Yerragondu N, Brown RD, Rabinstein A, Jahromi BS et al (2013) The triglyceride paradox in stroke survivors: a prospective study. Neurosci J 2013:870608PubMedPubMedCentralCrossRef Jain M, Jain A, Yerragondu N, Brown RD, Rabinstein A, Jahromi BS et al (2013) The triglyceride paradox in stroke survivors: a prospective study. Neurosci J 2013:870608PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Deng Q, Li S, Zhang H, Wang H, Gu Z, Zuo L, Wang L, Yan F (2019) Association of serum lipids with clinical outcome in acute ischaemic stroke: a systematic review and meta-analysis. J Clin Neurosci 59:236–244PubMedCrossRef Deng Q, Li S, Zhang H, Wang H, Gu Z, Zuo L, Wang L, Yan F (2019) Association of serum lipids with clinical outcome in acute ischaemic stroke: a systematic review and meta-analysis. J Clin Neurosci 59:236–244PubMedCrossRef
12.
Zurück zum Zitat Bevan S, Traylor M, Adib-Samii P, Malik R, Paul NLM, Jackson C, Farrall M, Rothwell PM, Sudlow C, Dichgans M, Markus HS (2012) Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke. 43:3161–3167PubMedCrossRef Bevan S, Traylor M, Adib-Samii P, Malik R, Paul NLM, Jackson C, Farrall M, Rothwell PM, Sudlow C, Dichgans M, Markus HS (2012) Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke. 43:3161–3167PubMedCrossRef
13.
Zurück zum Zitat Babu MS, Prabha TS, Kaul S, Al-Hazzani A, Shafi G, Roy S et al (2012) Association of genetic variants of fibrinolytic system with stroke and stroke subtypes. Gene. 495:76–80PubMedCrossRef Babu MS, Prabha TS, Kaul S, Al-Hazzani A, Shafi G, Roy S et al (2012) Association of genetic variants of fibrinolytic system with stroke and stroke subtypes. Gene. 495:76–80PubMedCrossRef
14.
Zurück zum Zitat Krajcoviechova A, Wohlfahrt P, Mayer O, Vanek J, Hajkova J, Hlinovsky D et al (2015) Tobacco smoking strongly modifies the association of prothrombin G20210A with undetermined stroke: consecutive survivors and population-based controls. Atherosclerosis 240:446–452PubMedCrossRef Krajcoviechova A, Wohlfahrt P, Mayer O, Vanek J, Hajkova J, Hlinovsky D et al (2015) Tobacco smoking strongly modifies the association of prothrombin G20210A with undetermined stroke: consecutive survivors and population-based controls. Atherosclerosis 240:446–452PubMedCrossRef
15.
Zurück zum Zitat Tasdemir S, Erdem HB, Sahin I, Ozel L, Ozdemir G, Eroz R, Tatar A (2016) Correlation with platelet parameters and genetic markers of thrombophilia panel (factor II g.20210G>A, factor V Leiden, MTHFR (C677T, A1298C), PAI-1, β-fibrinogen, factor XIIIA (V34L), glycoprotein IIIa (L33P)) in ischemic strokes. NeuroMolecular Med 18:170–176PubMedCrossRef Tasdemir S, Erdem HB, Sahin I, Ozel L, Ozdemir G, Eroz R, Tatar A (2016) Correlation with platelet parameters and genetic markers of thrombophilia panel (factor II g.20210G>A, factor V Leiden, MTHFR (C677T, A1298C), PAI-1, β-fibrinogen, factor XIIIA (V34L), glycoprotein IIIa (L33P)) in ischemic strokes. NeuroMolecular Med 18:170–176PubMedCrossRef
16.
Zurück zum Zitat They-They TP, Battas O, Nadifi S (2013) Synergistic effect of MTHFR C677T and F2 G20210A polymorphisms on ischemic stroke. Neurosci Bull 29:725–730PubMedPubMedCentralCrossRef They-They TP, Battas O, Nadifi S (2013) Synergistic effect of MTHFR C677T and F2 G20210A polymorphisms on ischemic stroke. Neurosci Bull 29:725–730PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Atadzhanov M, Mwaba MH, Mukomena PN, Lakhi S, Rayaprolu S, Ross OA et al (2013) Association of the APOE, MTHFR and ACE genes polymorphisms and stroke in Zambian patients. Neurol Int 5:69–72CrossRef Atadzhanov M, Mwaba MH, Mukomena PN, Lakhi S, Rayaprolu S, Ross OA et al (2013) Association of the APOE, MTHFR and ACE genes polymorphisms and stroke in Zambian patients. Neurol Int 5:69–72CrossRef
18.
Zurück zum Zitat Markoula S, Giannopoulos S, Kostoulas C, Tatsioni A, Bouba I, Maranis S, Georgiou I, Kyritsis AP (2011) Gender association of the angiotensin-converting enzyme gene with ischaemic stroke. J Renin-Angiotensin-Aldosterone Syst 12:510–515PubMedCrossRef Markoula S, Giannopoulos S, Kostoulas C, Tatsioni A, Bouba I, Maranis S, Georgiou I, Kyritsis AP (2011) Gender association of the angiotensin-converting enzyme gene with ischaemic stroke. J Renin-Angiotensin-Aldosterone Syst 12:510–515PubMedCrossRef
19.
Zurück zum Zitat Malueka RG, Dwianingsih EK, Sutarni S, Bawono RG, Bayuangga HF, Gofir A et al (2017) The D allele of the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism is associated with worse functional outcome of ischemic stroke. Int J Neurosci 7454:1–21 Malueka RG, Dwianingsih EK, Sutarni S, Bawono RG, Bayuangga HF, Gofir A et al (2017) The D allele of the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism is associated with worse functional outcome of ischemic stroke. Int J Neurosci 7454:1–21
20.
Zurück zum Zitat Martiskainen M, Oksala N, Pohjasvaara T, Kaste M, Oksala A, Karhunen PJ, Erkinjuntti T (2014) Βeta-fibrinogen gene promoter A -455 allele associated with poor longterm survival among 55-71 years old Caucasian women in Finnish stroke cohort. BMC Neurol 14:137PubMedPubMedCentralCrossRef Martiskainen M, Oksala N, Pohjasvaara T, Kaste M, Oksala A, Karhunen PJ, Erkinjuntti T (2014) Βeta-fibrinogen gene promoter A -455 allele associated with poor longterm survival among 55-71 years old Caucasian women in Finnish stroke cohort. BMC Neurol 14:137PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Shemirani AH, Antalfi B, Pongrácz E, Mezei ZA, Bereczky Z, Csiki Z (2014) Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke. Blood Coagul Fibrinolysis 25:364–368PubMedCrossRef Shemirani AH, Antalfi B, Pongrácz E, Mezei ZA, Bereczky Z, Csiki Z (2014) Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke. Blood Coagul Fibrinolysis 25:364–368PubMedCrossRef
22.
Zurück zum Zitat Saracevic A, Simundic AM, Celap I, Luzanic V (2013) Angiotensin-converting enzyme insertion/deletion polymorphism genotyping error: the cause and a possible solution to the problem. Mol Biol Rep 40:4459–4463PubMedCrossRef Saracevic A, Simundic AM, Celap I, Luzanic V (2013) Angiotensin-converting enzyme insertion/deletion polymorphism genotyping error: the cause and a possible solution to the problem. Mol Biol Rep 40:4459–4463PubMedCrossRef
23.
Zurück zum Zitat Fonarow GC, Saver JL, Smith EE, Broderick JP, Kleindorfer DO, Sacco RL, Pan W, Olson DM, Hernandez AF, Peterson ED, Schwamm LH (2012) Relationship of National Institutes of Health Stroke scale to 30-day mortality in Medicare beneficiaries with acute ischemic Stroke. J Am Heart Assoc 1:42–50PubMedPubMedCentralCrossRef Fonarow GC, Saver JL, Smith EE, Broderick JP, Kleindorfer DO, Sacco RL, Pan W, Olson DM, Hernandez AF, Peterson ED, Schwamm LH (2012) Relationship of National Institutes of Health Stroke scale to 30-day mortality in Medicare beneficiaries with acute ischemic Stroke. J Am Heart Assoc 1:42–50PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Ver HA (2011) The NIH stroke scale: a window into neurological status. Nursing Spectrum (Greater Chicago) 24:44–49 Ver HA (2011) The NIH stroke scale: a window into neurological status. Nursing Spectrum (Greater Chicago) 24:44–49
25.
Zurück zum Zitat Kim M, Kim M, Yoo HJ, Lee E, Chae JS, Lee S-H et al (2017) A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients. PLoS ONE 12:e0186693PubMedPubMedCentralCrossRef Kim M, Kim M, Yoo HJ, Lee E, Chae JS, Lee S-H et al (2017) A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients. PLoS ONE 12:e0186693PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Mahrooz A, Zargari M, Ansari V, Makhlough A, Hashemi-Sooteh MB (2016) Association of APOA5 gene promoter region -1131T>C polymorphism (rs662799) to plasma triglyceride level in patients with type 2 diabetic nephropathy. J Clin Diagn Res 10:BC09–BC13PubMedPubMedCentral Mahrooz A, Zargari M, Ansari V, Makhlough A, Hashemi-Sooteh MB (2016) Association of APOA5 gene promoter region -1131T>C polymorphism (rs662799) to plasma triglyceride level in patients with type 2 diabetic nephropathy. J Clin Diagn Res 10:BC09–BC13PubMedPubMedCentral
27.
Zurück zum Zitat Guardiola M, Cofán M, de Castro-Oros I, Cenarro A, Plana N, Talmud PJ, Masana L, Ros E, Civeira F, Ribalta J (2015) APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis. Atherosclerosis 240:98–104PubMedCrossRef Guardiola M, Cofán M, de Castro-Oros I, Cenarro A, Plana N, Talmud PJ, Masana L, Ros E, Civeira F, Ribalta J (2015) APOA5 variants predispose hyperlipidemic patients to atherogenic dyslipidemia and subclinical atherosclerosis. Atherosclerosis 240:98–104PubMedCrossRef
28.
Zurück zum Zitat Can Demirdöğen B, Şahin E, Türkanoğlu Özçelik A, Bek S, Demirkaya Ş, Adali O (2012) Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke. Mol Biol Rep 39:10459–10468PubMedCrossRef Can Demirdöğen B, Şahin E, Türkanoğlu Özçelik A, Bek S, Demirkaya Ş, Adali O (2012) Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke. Mol Biol Rep 39:10459–10468PubMedCrossRef
29.
Zurück zum Zitat Maasz A, Kisfali P, Jaromi L, Horvatovich K, Szolnoki Z, Csongei V, Safrany E, Sipeky C, Hadarits F, Melegh B (2008) Apolipoprotein A5 gene IVS3+G476A allelic variant confers susceptibility for development of ischemic stroke. Circ J 72:1065–1070PubMedCrossRef Maasz A, Kisfali P, Jaromi L, Horvatovich K, Szolnoki Z, Csongei V, Safrany E, Sipeky C, Hadarits F, Melegh B (2008) Apolipoprotein A5 gene IVS3+G476A allelic variant confers susceptibility for development of ischemic stroke. Circ J 72:1065–1070PubMedCrossRef
30.
Zurück zum Zitat Simundic AM, Nikolac N, Topic E, Basic-Kes V, Demarin V (2008) Are serum lipids measured on stroke admission prognostic? Clin Chem Lab Med 46(8):1163–1167PubMedCrossRef Simundic AM, Nikolac N, Topic E, Basic-Kes V, Demarin V (2008) Are serum lipids measured on stroke admission prognostic? Clin Chem Lab Med 46(8):1163–1167PubMedCrossRef
31.
Zurück zum Zitat Weir CJ, Sattar N, Walters MR, Lees KR (2003) Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovasc Dis 16:76–82PubMedCrossRef Weir CJ, Sattar N, Walters MR, Lees KR (2003) Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovasc Dis 16:76–82PubMedCrossRef
32.
Zurück zum Zitat Pikija S, Milevčić D, Trkulja V, Kidemet-Piskač S, Pavliček I, Sokol N (2006) Higher serum triglyceride level in patients with acute ischemic stroke is associated with lower infarct volume on CT brain scans. Eur Neurol 55:89–92PubMedCrossRef Pikija S, Milevčić D, Trkulja V, Kidemet-Piskač S, Pavliček I, Sokol N (2006) Higher serum triglyceride level in patients with acute ischemic stroke is associated with lower infarct volume on CT brain scans. Eur Neurol 55:89–92PubMedCrossRef
33.
Zurück zum Zitat Perovic E, Mrdjen A, Harapin M, Simundic AM (2016) Short term changes of serum lipids in acute ischemic stroke. Clin Lab 62:2107–2113PubMedCrossRef Perovic E, Mrdjen A, Harapin M, Simundic AM (2016) Short term changes of serum lipids in acute ischemic stroke. Clin Lab 62:2107–2113PubMedCrossRef
34.
Zurück zum Zitat Aparicio HJ, Himali JJ, Beiser AS, Davis-Plourde KL, Vasan RS, Kase CS et al (2017) Overweight, obesity, and survival after stroke in the Framingham heart study. J Am Heart Assoc 6:e004721PubMedPubMedCentralCrossRef Aparicio HJ, Himali JJ, Beiser AS, Davis-Plourde KL, Vasan RS, Kase CS et al (2017) Overweight, obesity, and survival after stroke in the Framingham heart study. J Am Heart Assoc 6:e004721PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Doehner W, Schenkel J, Anker SD, Springer J, Audebert H (2013) Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the tempis trial. Eur Heart J 34:268–277PubMedCrossRef Doehner W, Schenkel J, Anker SD, Springer J, Audebert H (2013) Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the tempis trial. Eur Heart J 34:268–277PubMedCrossRef
36.
Zurück zum Zitat Jang SY, Shin Y II, Kim DY, Sohn MK, Lee J, Lee SG et al (2015) Effect of obesity on functional outcomes at 6 months post-stroke among elderly Koreans: a prospective multicentre study. BMJ Open 5:e008712PubMedPubMedCentralCrossRef Jang SY, Shin Y II, Kim DY, Sohn MK, Lee J, Lee SG et al (2015) Effect of obesity on functional outcomes at 6 months post-stroke among elderly Koreans: a prospective multicentre study. BMJ Open 5:e008712PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Dehlendorff C, Andersen KK, Olsen TS (2014) Body mass index and death by stroke no obesity paradox. JAMA Neurol 71:978–984PubMedCrossRef Dehlendorff C, Andersen KK, Olsen TS (2014) Body mass index and death by stroke no obesity paradox. JAMA Neurol 71:978–984PubMedCrossRef
38.
39.
Zurück zum Zitat Kissela BM, Khoury JC, Alwell K, Moomaw CJ, Woo D, Adeoye O, Flaherty ML, Khatri P, Ferioli S, de Los Rios la Rosa F, Broderick JP, Kleindorfer DO (2012) Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology 79:1781–1787PubMedPubMedCentralCrossRef Kissela BM, Khoury JC, Alwell K, Moomaw CJ, Woo D, Adeoye O, Flaherty ML, Khatri P, Ferioli S, de Los Rios la Rosa F, Broderick JP, Kleindorfer DO (2012) Age at stroke: temporal trends in stroke incidence in a large, biracial population. Neurology 79:1781–1787PubMedPubMedCentralCrossRef
40.
41.
Zurück zum Zitat Wang Y, Rudd AG, Wolfe CDA (2013) Age and ethnic disparities in incidence of stroke over time: the South London stroke register. Stroke 44:3298–3304PubMedCrossRef Wang Y, Rudd AG, Wolfe CDA (2013) Age and ethnic disparities in incidence of stroke over time: the South London stroke register. Stroke 44:3298–3304PubMedCrossRef
42.
Zurück zum Zitat Roach REJ, Roshani S, Meijer K, Hamulyák K, Lijfering WM, Prins MH, Büller HR, Middeldorp S (2011) Risk of cardiovascular disease in double heterozygous carriers and homozygous carriers of F5 R506Q (factor V Leiden) and F2 (prothrombin) G20210A: a retrospective family cohort study. Br J Haem 153:134–136CrossRef Roach REJ, Roshani S, Meijer K, Hamulyák K, Lijfering WM, Prins MH, Büller HR, Middeldorp S (2011) Risk of cardiovascular disease in double heterozygous carriers and homozygous carriers of F5 R506Q (factor V Leiden) and F2 (prothrombin) G20210A: a retrospective family cohort study. Br J Haem 153:134–136CrossRef
43.
Zurück zum Zitat Beye A, Pindur G (2017) Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke. Clin Hemorheol Microcirc 67:261–266PubMedCrossRef Beye A, Pindur G (2017) Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke. Clin Hemorheol Microcirc 67:261–266PubMedCrossRef
44.
Zurück zum Zitat Herm J, Hoppe B, Siegerink B, Nolte CH, Koscielny J, Haeusler KG (2017) A prothrombotic score based on genetic polymorphisms of the hemostatic system differs in patients with ischemic stroke, myocardial infarction, or peripheral arterial occlusive disease. Front Cardiovasc Med 4:39PubMedPubMedCentralCrossRef Herm J, Hoppe B, Siegerink B, Nolte CH, Koscielny J, Haeusler KG (2017) A prothrombotic score based on genetic polymorphisms of the hemostatic system differs in patients with ischemic stroke, myocardial infarction, or peripheral arterial occlusive disease. Front Cardiovasc Med 4:39PubMedPubMedCentralCrossRef
Metadaten
Titel
Genetic and lifestyle predictors of ischemic stroke severity and outcome
verfasst von
Ivana Celap
Nora Nikolac Gabaj
Vida Demarin
Vanja Basic Kes
Ana-Maria Simundic
Publikationsdatum
20.07.2019
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 12/2019
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-04006-y

Weitere Artikel der Ausgabe 12/2019

Neurological Sciences 12/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.